Aging and the nigro-striatal pathway

  • F. F. Cruz-Sánchez
  • A. Cardozo
  • C. Castejón
  • E. Tolosa
  • M. L. Rossi
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 51)


Aging is associated with a progressive impairment in motor function. This feature, together with the decline in mental function, could be considered as an aging syndrome which may finally compromise the ability of the elderly to maintain an active, independent life-style.

In the present paper a wide variety of morphological aspects, which have been classically related to brain aging and others such as cytoskeletal changes, the role of growth factors and molecular changes, will be reviewed focusing on aging of the nigrostriatal pathway. In addition to sharing features of aging common to other structures, it is likely that the nigrostriatal pathway has specific characteristics derived from its particular molecular characteristics and/or from a selective vulnerability to aging.

To gain further insight into the aging syndrome, the acquisition of rigorous criteria for selecting control cases is paramount. The improvement of methods for the preservation of human tissue is also crucial.


Substantia Nigra Senile Plaque Dystrophic Neurites Nigrostriatal Pathway Cytoskeletal Change 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arriagada PV, Marzloff K, Hyman BT (1992) Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease. Neurology 42: 1681–1688.PubMedCrossRefGoogle Scholar
  2. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandien R, Rosenthal A, Hefti F (1995) Mesencephalic dopaminergic neurons protected by GDNF from axotomyinduced degeneration in the adult brain. Nature 373: 339–341.PubMedCrossRefGoogle Scholar
  3. Boatell MLI, Mahy N, Cardozo A, Ambrosio S, Tolosa E, Cruz-Sánchez FF (1992) Neuronal changes in the nigrostriatal pathway of l-Methl-4-Phenylpyridine- treated mice. Meth Find Exp Clin Pharmacol 14(10): 781–787.Google Scholar
  4. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239–259.PubMedCrossRefGoogle Scholar
  5. Burgoyne RD, Cambray-Deakin MA (1988) The cellular neurobiology of neuronal development: the cerebellar granule cell. Brain Res Rev 13: 77–101.CrossRefGoogle Scholar
  6. Calne DB, Peppard RF (1987) Aging of the nigrostriatal pathway in humans. Can J Neurol Sci 14: 424–427.PubMedGoogle Scholar
  7. Calne DB, Eisen A, McGeer E, Spencer P (1986) Alzheimer’s disease, Parkinson’s disease and motor neurone disease: abiotrophic interaction between ageing and environment? Lancet (Nov 8): 1067–1070.Google Scholar
  8. Cheng B, Mattson MP (1994) NT-3 and BDNF protect CNS neurons against metabolic/ excitotoxic insults. Brain Res 640: 56–67.PubMedCrossRefGoogle Scholar
  9. Crutcher KA (1990) Age-related decrease in sympathetic sprouting is primarily due to decreased target receptivity: implications for understanding brain aging. Neurobiol Aging 11: 175–183.PubMedCrossRefGoogle Scholar
  10. Cruz-Sánchez FF (1994) Antigenic determinant properties of neurofibrillary tangles. Relevance to progressive supranuclear palsy. J Neural Transm [Suppl] 42: 165–178.Google Scholar
  11. Cruz-Sánchez FF, Cardozo A, Ambrosio S, Tolosa E, Mahy N (1993) Plasticity of the nigrostriatal system in MPTP-treated mice. Mol Chem Neuropathol 19: 163–176.PubMedCrossRefGoogle Scholar
  12. Cruz-Sánchez FF, Cardozo A, Tolosa E (1995) Neuronal changes in the substantia nigra with aging: a Golgi study. J Neuropathol Exp Neurol 54: 74–81.PubMedCrossRefGoogle Scholar
  13. Daniel SE (1995) Parkinson’s disease. In: Cruz-Sánchez FF, Ravid R, Cuzner ML (eds). Neuropathological diagnostic criteria for brain banking. IOS Press, Amsterdam.Google Scholar
  14. Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain 114: 2283–2301.PubMedCrossRefGoogle Scholar
  15. Finch CE, Morgan DG (1990) RNA and protein metabolism in the aging brain. Ann Rev Neurosci 13: 75–87.PubMedCrossRefGoogle Scholar
  16. Gibb WRG, Lees AJ (1991) Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease. J Neurol Neurosurg Psychiatry 54: 388–396.PubMedCrossRefGoogle Scholar
  17. Gsell W, Lange KW, Pfeuffer R, Heckers S, Heisen H, Senitz D, Jellinger K, Ransmayr G, Wichart I, Vock R, Beckmann H, Riederer P (1993) How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm [Suppl] 39: 31–70.Google Scholar
  18. Haas AL, Bright PM (1985) The immunochemical detection and quantification of intracellular ubiquitin-protein conjugates. J Biol Biochem 260: 12464–12473.Google Scholar
  19. Hodge CF (1894) Changes in the ganglion cells from birth to senile death. Observations on man and honey-bee. J Physiol 17: 129–134.Google Scholar
  20. Jelsma TN, Aguayo AJ (1994) Trophic factors. Curr Opin Neurobiol 4: 717–725.PubMedCrossRefGoogle Scholar
  21. Kaminska B, Kaczmarek L (1993) Robust induction of AP-1 transcription factor DNA binding activity in the hippocampus of aged rats. Neurosci Lett 153: 189–191.PubMedCrossRefGoogle Scholar
  22. Landfield PW, Rose G, Sandles L, Wohlstadter TC, Lynch G (1994) Patterns of astroglial hypertrophy and neuronal degeneration in the hippocampus of aged, memorydeficient rats. J Gerontol 32: 3–12.Google Scholar
  23. Leigh PN, Probst A, Dale GE, Power DP, Brion J-P, Dodson A, Anderton BH (1989) New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (Beri) 79: 61–72.CrossRefGoogle Scholar
  24. Lindsay RM (1995) Neuron saving schemes. Nature 373: 289–290.PubMedCrossRefGoogle Scholar
  25. Lindsay RM, Wiegand SJ, Altar A, DiStefano P (1994) Neurotrophic factors: from molecule to man. TINS 17: 182–190. PubMedGoogle Scholar
  26. Linnemann D, Skarsfelt T (1994) Regional changes in expression of NCAM, GFAP, S100 in aging rat brain. Neurobiol Aging 15: 651–655. PubMedCrossRefGoogle Scholar
  27. Linnemann D, Gaardsvoll H, Olsen M, Bock E (1993) Expression of NCAM mRNA and polypeptides in aging rat brain. Int J Dev Neurosci 11: 71–81. PubMedCrossRefGoogle Scholar
  28. Lopez Torres M, Perz Campo R, Fernandez A, Barba C, Barja de Quiroga G (1993) Brain glutathione reductase induction increases early survival and decreases lipofuscin accumulation in aging frogs. J Neurosci Res 34: 233–242.PubMedCrossRefGoogle Scholar
  29. Lowe J, Blanchard A, Morrel K, Lennox G, Reynolds L, Billet M, Landon M, Mayer RJ. (1998) Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson’s disease, Pick’s disease and Alzheimer’s disease, as well as Rosenthal fibres in cerebellar astrocytomas cytoplasmic bodies in muscle and Mallory bodies in alcoholic liver disease. J Pathol 155: 9–15CrossRefGoogle Scholar
  30. Machado-Salas J, Scheibel ME, Scheibel AB (1977) Neuronal changes in the aging mouse: spinal cord and lower brain stem. Exp Neurol 54: 504–512.PubMedCrossRefGoogle Scholar
  31. Magnoni MS, Govoni S, Battami F, Trabucchi M (1991) The aging brain: protein phosphorylation as a target of changes in neuronal function. Life Sci 48: 373–385.PubMedCrossRefGoogle Scholar
  32. Mann DMA, Yates PO (1974) Lipoprotein pigments - their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. Brain 97: 489–498.Google Scholar
  33. Mann DMA, Yates PO, Marcyniuk B (1984) Monoaminergic neurotransmitter systems in presenile Alzheimer’s disease and in senile dementia of Alzheimer type. Clin Neuropathol 3(5): 199–205.PubMedGoogle Scholar
  34. Mannetto V, Perry G, Tabaton M, Mulvihill P, Fried VA, Smith HT, Gambetti P, Autulio Gambetti L (1988) Ubiquitin is associated with abnormal cytoplasmic filaments char-acteristic of neurodegenerative diseases. Proc Natl Acad Sci USA 85: 4501–4505.CrossRefGoogle Scholar
  35. McGeer PL, McGeer EG, Suzuki JS (1977) Aging and the extrapyramidal function. Arch Neurol 34: 33–35.PubMedCrossRefGoogle Scholar
  36. Migheli A, Attanasio A, Pezzulo T, Gullotta F, Giordana MT, Schiffer D (1992) Age related ubiquitin deposits in dystrophic neuntes: an immunoelectron microscopicstudy. Neuropathol Appi Neurobiol 18: 3–11.CrossRefGoogle Scholar
  37. Moral A, Cardozo A, Rossi M, Tolosa E, Cruz-Sánchez FF (1994) Spinal motor neuronsin aging: a morphological and immunohistochemical study (Abstract). Brain Neuropathol 4: 577.Google Scholar
  38. Nixon RA (1993) The regulation of neurofilament protein dynamics by phosphorylation: clue to neurofibrillary pathobiology. Brain Pathol 3: 29–38.PubMedCrossRefGoogle Scholar
  39. Patt S, Gertz HJ, Lieselote G, Cervós-Navarro J (1991) Pathological changes in dendrites of substantia nigra neurons in Parkinson’s disease: a Golgi study. Histol Histopathol 6: 373–380.PubMedGoogle Scholar
  40. Ramón-Moliner E (1970) The Golgi-Cox technique. In: Nauta WJH, Ebbesson SOE (eds) Contemporary research methods in neuroanatomy. Springer, New York, pp 32–55.CrossRefGoogle Scholar
  41. Ravid R, Swaab DF, van Zwieten EJ, Salehi A (1995) Controls are what makes a brain bank go round. In: Cruz-Sánchez FF, Ravid R, Cuzner ML (eds) Neuropathological diagnostic criteria for brain banks. IOS Press, Amsterdam, pp 4–13.Google Scholar
  42. Rechsteiner M (1991) Natural substrate of the ubiquitin proteolytic pathway. Cell 66: 615–618.PubMedCrossRefGoogle Scholar
  43. Roth GS, Joseph JA, Preston Mason R (1995) Membrane alterations as causes of impaired signal transduction in Alzheimer’s disease and aging. TINS 18: 203–206.PubMedGoogle Scholar
  44. Rylett RJ, Williams LR (1994) Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS. TINS 17: 486–490.PubMedGoogle Scholar
  45. Selkoe DJ (1992) Aging brain, aging mind. Sci Am 267: 134–142.PubMedCrossRefGoogle Scholar
  46. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical ageing in Alzheimer’s disease. TINS 18: 172–176.PubMedGoogle Scholar
  47. Scheibel ME, Scheibel AB (1970) The rapid Golgi method. Indian summer or renaissance? In: Nauta WJH, Ebbesson SOE (eds) Contemporary research methods in neuroanatomy. Springer, New York, pp 1–11.CrossRefGoogle Scholar
  48. Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB (1976) Progressive dendritic changes in the aging human limbic system. Exp Neurol 47: 392–403.CrossRefGoogle Scholar
  49. Scheibel ME, Lindsay RD, Tomiyasu U, Scheibel AB (1977) The aging human Betz cell. Exp Neurol 56: 598–609.PubMedCrossRefGoogle Scholar
  50. Teräväinen H, Calne DB (1983) Motor system in normal aging and Parkinson’s disease. In: Katzman R, Terry R (eds) The neurology of aging. Davis, Philadelphia, pp 85–109.Google Scholar
  51. Thiessen B, Rajput AH, Laverty W, Desai H(1990) Age, environments and the number of substantia nigra neurons. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH (eds) Parkinson’s disease: anatomy, pathology, and therapy. Raven Press, New York, pp 201–206 (Adv Neurol 53).Google Scholar
  52. Tomac A, Lindqvist E, Lin LF H, Ögren SO, Young D, Hoffer BJ, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373: 335–339.PubMedCrossRefGoogle Scholar
  53. Tomlinson BE, Irving D (1977) The number of motor neurons in the human lumbosacral cord throughout life. J Neurol Sci 34: 213–219.PubMedCrossRefGoogle Scholar
  54. Valverde F (1970) The Golgi method. A tool for comparative structural analyses. In: Nauta WJH, Ebbesson SOE (eds) Contemporary research methods in neuro¬anatomy. Springer, New York, pp 12–31.CrossRefGoogle Scholar
  55. Vickers JC, Riederer BM, Marugg RA, Buée-Scerrer V, Buée L, Delacourte A, Morrison JH (1994) Alterations in neurofilament protein immunoreactivity in human hippoc-ampal neurons related to normal aging and Alzheimer’s disease. Neurosci 62(1): 1–13.CrossRefGoogle Scholar
  56. Wiedenmann B, Franke W (1985) Identification and location of synapthophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41: 1017–1028.PubMedCrossRefGoogle Scholar
  57. Williams EJ, Furness J, Walsh FS, Doherty P (1994) Activation of FGF receptor underlies neurite outgrowth stimulated by LI, N-CAM and N-cadherin. Neuron 13: 583–594.PubMedCrossRefGoogle Scholar
  58. Yasuhara O, Kawamata T, Yoshinari A, McGeer EG, McGeer PL (1994) Two types of dystrophic neuntes in senile plaques of Alzheimer’s disease and elderly non-demented cases. Neurosci Lett 171: 73–76.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1997

Authors and Affiliations

  • F. F. Cruz-Sánchez
    • 1
  • A. Cardozo
    • 1
  • C. Castejón
    • 1
  • E. Tolosa
    • 1
  • M. L. Rossi
    • 1
  1. 1.Neurological Tissue Bank, Hospital ClinicUniversity of BarcelonaSpain

Personalised recommendations